The clinical approach is to manage symptoms supportively while allowing time for physiological adaptation
Always confirm with your healthcare provider before adding berberine to any GLP-1 regimen
At the 10 mg dose: Participants lost an average of 21.4% of their starting body weight
The most commonly reported side effects are gastrointestinal, including nausea, vomiting, and diarrhea
Similar to vision concerns, people who say they were impacted by gastroparesis are filing lawsuits against the makers of Ozempic, Mounjaro and other GLP-1 drugs
Source: IFEBP Another factor relating to employer concerns is that obesity is not considered a disease entity like diabetes, and employers and insurance providers cannot or do not want to cover medications for a disease entity they dont think exists, Bajaj said